Prognostic impact of CD133 expression in Endometrial Cancer Patients

Prognostic impact of CD133 expression in Endometrial Cancer Patients

Abstract To assess the impact of CD133 expression on the prognosis of endometrioid endometrial carcinoma (EEC). We retrospectively assessed CD133 expression in tissue microarray of 116 surgically treated FIGO I-III EEC. Tumors with ≥10% of CD133-expressing cells were considered CD133-positive (CD133...

Full description

Saved in:
Bibliographic Details
Main Authors: G. Mancebo, J. M. Sole-Sedeno, O. Pino, E. Miralpeix, S. Mojal, L. Garrigos, B. Lloveras, P. Navarro, J. Gibert, M. Lorenzo, I. Aran, R. Carreras, F. Alameda
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/3ddb17437f2a4cff903814dfb8c2706d
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/3ddb17437f2a4cff903814dfb8c2706d

Similar Items